01
Cash & equivalents decreased 44.8%
Cash & equivalents changed -44.8% from the comparable as-filed period.
$12.5M→$6.9MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTBriaCell Therapeutics Corp.'s latest supported as-filed period reports net income of -$7.2M, 16.9% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -44.8% from the comparable as-filed period.
Net income changed -16.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -20.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
BCTX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-030286SEC ↗10-QJun 9, 2026Period Apr 30, 20260001493152-26-027928SEC ↗8-KJun 3, 2026Period May 31, 20260001493152-26-026953SEC ↗8-KMar 31, 2026Period Mar 31, 20260001493152-26-014156SEC ↗10-QMar 10, 2026Period Jan 31, 20260001493152-26-009557SEC ↗8-KMar 9, 2026Period Mar 5, 20260001493152-26-009382SEC ↗8-KFeb 20, 2026Period Feb 18, 20260001493152-26-007587SEC ↗8-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +24.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-04-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-002430